Riskpilot← Back to searchSign inGet full accessUniMind AB
ABActiveOrg 5590203294Anders Lundströms Gata 18Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20150 employees
Revenue 2024
SEK 0
EBITDA margin
—
+12% vs 2023
Equity ratio
60.3%
Financial strength
Net profit 2024
SEK -97K
+10% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -85K | +12% |
| Net profit | SEK -97K | +10% |
| Total assets | SEK 88K | -36% |
| Equity | SEK 53K | +0% |
| Employees | 0 | — |
Legal name
UniMind AB
Org number
5590203294
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9 juli 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva specialistläkarverksamhet inom öppen- och sluten vård, erbjuda konsulttjänster inom medicinsk forskning och utbildning samt bedriva import och export av medicinska produkter och tjänster.
Address
Anders Lundströms Gata 18
Email
amir.samadi@unimind.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 104 | 33 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −87 | −34 | −94 | −96 | −85 |
| Depreciation & amort. | −0 | −0 | — | −13 | −13 |
| EBIT | −87 | −34 | −94 | −109 | −97 |
| Net financials | — | — | 0 | 1 | 1 |
| Profit before tax | −87 | −34 | −94 | −108 | −97 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −87 | −34 | −94 | −108 | −97 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 39 | 68 | 65 | 136 | 88 |
| Equity | 26 | 50 | 51 | 53 | 53 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 13 | 18 | 14 | 84 | 35 |
| Total debt | 13 | 18 | 14 | 84 | 35 |
EBITDA margin
-8471400.0%
This company
15.8%
Market median
-53616556% vs market
20202024
Equity ratio
60.3%
This company
38.2%
Market median
+58% vs market
20202024
Return on equity
-182.8%
This company
18.4%
Market median
-1093% vs market
20202024
Net profit margin
-9681800.0%
This company
8.1%
Market median
-119528495% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of UniMind AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Amir Hossein Samadi Ahadi | Board of Directors | 0 companies |
| Shima Yasini | Deputy Board Member | 0 companies |